Literature DB >> 21589067

N-(2-Chloro-eth-yl)pyrazine-2-carboxamide.

Camilo H da Silva Lima, Marcus V N de Souza, Solange M S V Wardell, James L Wardell, Edward R T Tiekink.   

Abstract

In the title mol-ecule, C(7)H(8)ClN(3)O, the pyrazine and amide groups are almost co-planar [N-C-C-N torsion angle = -2.4 (2) °], a conformation stabilized by an intra-molecular N-H⋯N hydrogen bond. The chloro-ethyl group lies out of the plane [N-C-C-Cl = -65.06 (17) °]. In the crystal, the presence of N-H⋯N hydrogen bonds leads to the formation of a C(6) supra-molecular chain along the b axis. The carbonyl-O atom accepts two C-H⋯O inter-actions. These, plus Cl⋯Cl short contacts [3.3653 (6) Å], consolidate the packing of the chains in the crystal.

Entities:  

Year:  2010        PMID: 21589067      PMCID: PMC3009184          DOI: 10.1107/S1600536810041656

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the anti­mycobacterial activity of pyrazinamide, see: Chaisson et al. (2002 ▶); Gordin et al. (2000 ▶); de Souza (2006 ▶). For structural studies on n class="Chemical">pyrazinamide derivatives; see: Wardell et al. (2008 ▶); Baddeley et al. (2009 ▶); Howie et al. (2010a ▶,b ▶,c ▶,d ▶).

Experimental

Crystal data

C7H8ClN3O M = 185.61 Monoclinic, a = 4.4639 (2) Å b = 10.6865 (6) Å c = 17.3583 (9) Å β = 93.028 (3)° V = 826.89 (7) Å3 Z = 4 Mo Kα radiation μ = 0.41 mm−1 T = 120 K 0.28 × 0.18 × 0.03 mm

Data collection

Nonius KappaCCD diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 2007 ▶) T min = 0.631, T max = 0.746 16245 measured reflections 1867 independent reflections 1628 reflections with I > 2σ(I) R int = 0.044

Refinement

R[F 2 > 2σ(F 2)] = 0.036 wR(F 2) = 0.110 S = 1.15 1867 reflections 112 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.23 e Å−3 Δρmin = −0.37 e Å−3 Data collection: COLLECT (Hooft, 1998 ▶); cell refinement: DENZO (Otwinowski & Minor, 1997 ▶) and COLLECT; data reduction: DENZO and COLLECT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 (Farrugia, 1997 ▶) and DIAMOND (Brandenburg, 2006 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablocks general, I. DOI: 10.1107/S1600536810041656/hb5682sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810041656/hb5682Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C7H8ClN3OF(000) = 384
Mr = 185.61Dx = 1.491 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 25954 reflections
a = 4.4639 (2) Åθ = 2.9–27.5°
b = 10.6865 (6) ŵ = 0.41 mm1
c = 17.3583 (9) ÅT = 120 K
β = 93.028 (3)°Prism, colourless
V = 826.89 (7) Å30.28 × 0.18 × 0.03 mm
Z = 4
Nonius KappaCCD diffractometer1867 independent reflections
Radiation source: Enraf Nonius FR591 rotating anode1628 reflections with I > 2σ(I)
10 cm confocal mirrorsRint = 0.044
Detector resolution: 9.091 pixels mm-1θmax = 27.5°, θmin = 3.0°
φ and ω scansh = −5→5
Absorption correction: multi-scan (SADABS; Sheldrick, 2007)k = −13→13
Tmin = 0.631, Tmax = 0.746l = −22→22
16245 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.036Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.110H atoms treated by a mixture of independent and constrained refinement
S = 1.15w = 1/[σ2(Fo2) + (0.0577P)2 + 0.3276P] where P = (Fo2 + 2Fc2)/3
1867 reflections(Δ/σ)max < 0.001
112 parametersΔρmax = 0.23 e Å3
1 restraintΔρmin = −0.37 e Å3
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.65306 (10)0.64380 (4)0.49830 (2)0.02780 (17)
O10.7056 (3)1.04630 (12)0.60138 (7)0.0247 (3)
N10.8112 (3)0.84349 (13)0.63161 (8)0.0195 (3)
H1n0.785 (5)0.7824 (15)0.6637 (10)0.028*
N20.4415 (3)0.85341 (14)0.75082 (8)0.0222 (3)
N30.1647 (4)1.07915 (15)0.78848 (9)0.0275 (4)
C10.6754 (4)0.95343 (16)0.64249 (9)0.0182 (3)
C20.4763 (4)0.95775 (15)0.70976 (9)0.0180 (3)
C30.2635 (4)0.86226 (18)0.80989 (10)0.0249 (4)
H30.22730.78970.83960.030*
C40.1292 (4)0.97467 (19)0.82923 (10)0.0264 (4)
H40.00870.97720.87270.032*
C50.3352 (4)1.06922 (17)0.72769 (10)0.0229 (4)
H50.36071.14030.69590.028*
C61.0072 (4)0.82477 (17)0.56832 (9)0.0212 (4)
H6A1.14990.75650.58210.025*
H6B1.12520.90200.56130.025*
C70.8395 (4)0.79260 (17)0.49280 (10)0.0232 (4)
H7A0.98230.79000.45110.028*
H7B0.68940.85860.47990.028*
U11U22U33U12U13U23
Cl10.0327 (3)0.0252 (3)0.0255 (3)−0.00579 (17)0.00184 (18)−0.00416 (17)
O10.0294 (7)0.0222 (7)0.0229 (6)−0.0018 (5)0.0045 (5)0.0058 (5)
N10.0221 (7)0.0200 (8)0.0164 (7)−0.0010 (6)0.0025 (5)0.0017 (5)
N20.0248 (8)0.0230 (8)0.0190 (7)−0.0010 (6)0.0023 (6)0.0019 (6)
N30.0312 (8)0.0271 (9)0.0245 (8)−0.0003 (6)0.0048 (6)−0.0055 (6)
C10.0173 (7)0.0210 (8)0.0163 (7)−0.0040 (6)−0.0011 (6)−0.0017 (6)
C20.0190 (8)0.0194 (8)0.0152 (7)−0.0036 (6)−0.0014 (6)−0.0013 (6)
C30.0293 (9)0.0279 (10)0.0179 (8)−0.0026 (7)0.0042 (7)0.0026 (7)
C40.0282 (9)0.0333 (10)0.0181 (8)−0.0029 (8)0.0047 (7)−0.0031 (7)
C50.0272 (9)0.0211 (9)0.0206 (8)−0.0024 (7)0.0028 (7)−0.0015 (7)
C60.0189 (8)0.0253 (9)0.0199 (8)−0.0018 (7)0.0046 (6)−0.0006 (7)
C70.0273 (9)0.0237 (9)0.0190 (8)−0.0025 (7)0.0044 (7)0.0011 (7)
Cl1—C71.7997 (19)C2—C51.390 (2)
O1—C11.234 (2)C3—C41.391 (3)
N1—C11.340 (2)C3—H30.9500
N1—C61.454 (2)C4—H40.9500
N1—H1n0.870 (10)C5—H50.9500
N2—C31.334 (2)C6—C71.514 (2)
N2—C21.337 (2)C6—H6A0.9900
N3—C41.336 (3)C6—H6B0.9900
N3—C51.338 (2)C7—H7A0.9900
C1—C21.505 (2)C7—H7B0.9900
C1—N1—C6121.46 (14)C3—C4—H4119.0
C1—N1—H1N119.4 (14)N3—C5—C2121.86 (17)
C6—N1—H1N119.1 (14)N3—C5—H5119.1
C3—N2—C2116.20 (15)C2—C5—H5119.1
C4—N3—C5116.09 (16)N1—C6—C7113.30 (14)
O1—C1—N1124.03 (15)N1—C6—H6A108.9
O1—C1—C2120.73 (15)C7—C6—H6A108.9
N1—C1—C2115.24 (14)N1—C6—H6B108.9
N2—C2—C5121.91 (15)C7—C6—H6B108.9
N2—C2—C1118.55 (15)H6A—C6—H6B107.7
C5—C2—C1119.53 (15)C6—C7—Cl1111.32 (12)
N2—C3—C4121.91 (17)C6—C7—H7A109.4
N2—C3—H3119.0Cl1—C7—H7A109.4
C4—C3—H3119.0C6—C7—H7B109.4
N3—C4—C3121.95 (16)Cl1—C7—H7B109.4
N3—C4—H4119.0H7A—C7—H7B108.0
C6—N1—C1—O1−0.6 (2)C2—N2—C3—C4−2.0 (3)
C6—N1—C1—C2179.20 (13)C5—N3—C4—C30.4 (3)
C3—N2—C2—C50.1 (2)N2—C3—C4—N31.8 (3)
C3—N2—C2—C1179.85 (15)C4—N3—C5—C2−2.3 (3)
O1—C1—C2—N2177.44 (15)N2—C2—C5—N32.2 (3)
N1—C1—C2—N2−2.4 (2)C1—C2—C5—N3−177.58 (15)
O1—C1—C2—C5−2.8 (2)C1—N1—C6—C7−83.3 (2)
N1—C1—C2—C5177.37 (15)N1—C6—C7—Cl1−65.06 (17)
D—H···AD—HH···AD···AD—H···A
N1—H1n···N20.87 (2)2.34 (2)2.7162 (19)107 (1)
N1—H1n···N3i0.87 (2)2.33 (2)3.146 (2)156 (2)
C5—H5···N2ii0.952.603.212 (2)123
C7—H7A···O1iii0.992.443.180 (2)131
C7—H7B···O1iv0.992.423.337 (2)153
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1n⋯N20.87 (2)2.34 (2)2.7162 (19)107 (1)
N1—H1n⋯N3i0.87 (2)2.33 (2)3.146 (2)156 (2)
C5—H5⋯N2ii0.952.603.212 (2)123
C7—H7A⋯O1iii0.992.443.180 (2)131
C7—H7B⋯O1iv0.992.423.337 (2)153

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

  5 in total

1.  Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.

Authors:  Richard E Chaisson; Joan Armstrong; John Stafford; Jonathan Golub; Sarah Bur
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.

Authors:  F Gordin; R E Chaisson; J P Matts; C Miller; M de Lourdes Garcia; R Hafner; J L Valdespino; J Coberly; M Schechter; A J Klukowicz; M A Barry; R J O'Brien
Journal:  JAMA       Date:  2000-03-15       Impact factor: 56.272

4.  Patterns of hydrogen bonding in mono- and di-substituted N-arylpyrazinecarboxamides.

Authors:  Solange M S V Wardell; Marcus V N de Souza; Thatyana R A Vasconcelos; Marcelle de L Ferreira; James L Wardell; John N Low; Christopher Glidewell
Journal:  Acta Crystallogr B       Date:  2008-01-17

5.  N'-[(E)-2,6-Dichloro-benzyl-idene]pyrazine-2-carbohydrazide.

Authors:  R Alan Howie; Marcus V N de Souza; Solange M S V Wardell; James L Wardell; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.